Kymera Therapeutics

Kymera Therapeutics to Host Virtual R&D Day on December 16, 2021

WATERTOWN, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced it will host a virtual R&D Day for analysts and